Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Return on Invested Capital (2022 - 2024)

Historic Return on Invested Capital for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to 0.5%.

  • Centessa Pharmaceuticals' Return on Invested Capital fell 800.0% to 0.5% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.5%, marking a year-over-year decrease of 800.0%. This contributed to the annual value of 0.55% for FY2024, which is 300.0% down from last year.
  • According to the latest figures from Q3 2025, Centessa Pharmaceuticals' Return on Invested Capital is 0.5%, which was down 800.0% from 0.44% recorded in Q2 2025.
  • Centessa Pharmaceuticals' Return on Invested Capital's 5-year high stood at 0.4% during Q1 2025, with a 5-year trough of 0.66% in Q1 2023.
  • Over the past 4 years, Centessa Pharmaceuticals' median Return on Invested Capital value was 0.57% (recorded in 2023), while the average stood at 0.53%.
  • Examining YoY changes over the last 5 years, Centessa Pharmaceuticals' Return on Invested Capital showed a top increase of 2000bps in 2025 and a maximum decrease of -800bps in 2025.
  • Over the past 4 years, Centessa Pharmaceuticals' Return on Invested Capital (Quarter) stood at 0.6% in 2022, then rose by 1bps to 0.59% in 2023, then surged by 32bps to 0.4% in 2024, then dropped by -24bps to 0.5% in 2025.
  • Its last three reported values are 0.5% in Q3 2025, 0.44% for Q2 2025, and 0.4% during Q1 2025.